Two pharmaceutical giants, Vertex Pharmaceuticals and CRISPR Therapeutics, join forces to develop a new technology in gene editing in the hopes to determine a treatment for cystic fibrosis. This collaboration could lead to the discovery of a potent treatment for genetic diseases.